Correlation Between Telix Pharmaceuticals and Australia

Can any of the company-specific risk be diversified away by investing in both Telix Pharmaceuticals and Australia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Telix Pharmaceuticals and Australia into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Telix Pharmaceuticals and Australia and New, you can compare the effects of market volatilities on Telix Pharmaceuticals and Australia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Telix Pharmaceuticals with a short position of Australia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Telix Pharmaceuticals and Australia.

Diversification Opportunities for Telix Pharmaceuticals and Australia

0.13

Correlation Coefficient

Telix Pharmaceuticals  Australia

Average diversification

The 3 months correlation between Telix and Australia is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Telix Pharmaceuticals and Australia and New in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Australia and New and Telix Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Telix Pharmaceuticals are associated (or correlated) with Australia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Australia and New has no effect on the direction of Telix Pharmaceuticals i.e., Telix Pharmaceuticals and Australia go up and down completely randomly.

Pair Corralation between Telix Pharmaceuticals and Australia

Assuming the 90 days trading horizon Telix Pharmaceuticals is expected to generate 1.76 times more return on investment than Australia. However, Telix Pharmaceuticals is 1.76 times more volatile than Australia and New. It trades about 0.19 of its potential returns per unit of risk. Australia and New is currently generating about -0.11 per unit of risk. If you would invest  2,069  in Telix Pharmaceuticals on September 21, 2024 and sell it today you would earn a total of  498.00  from holding Telix Pharmaceuticals or generate 24.07% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Telix Pharmaceuticals  vs.  Australia and New

Telix Pharmaceuticals

Risk-Adjusted Performance

14 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Telix Pharmaceuticals are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Telix Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Australia and New

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Australia and New has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Pair Trading with Telix Pharmaceuticals and Australia

The main advantage of trading using opposite Telix Pharmaceuticals and Australia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Telix Pharmaceuticals position performs unexpectedly, Australia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Australia will offset losses from the drop in Australia's long position.

The idea behind Telix Pharmaceuticals and Australia and New pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..